Previous 10 | Next 10 |
home / stock / biovf / biovf news
Swedish Orphan Biovitrum AB ( OTCPK:BIOVF ), the biotech also known as Sobi, has received the FDA’s Emergency Use Authorization (EUA) for its anti-inflammatory medication Kineret as a treatment for certain hospitalized patients with COVID-19. The FDA decision was backed...
The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2022 Q3 earnings call. For further details see: Swedish Orphan Biovitrum AB (publ) 2022 Q3 - Results - Earnings Call Presentation
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2022 Earnings Conference Call October 27, 2022 07:00 ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Anders Ullman - Head R&D and Medical Affairs and Chie...
Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q3 GAAP EPS of SEK 1.52. Revenue of SEK 4B (+6.4% Y/Y). EBITA of SEK 1,241M; EBITA margin of 31%. EBIT of SEK 699M. Cash flow from operating activities SEK 780M. 2022 outlo...
Swedish Orphan Biovitrum AB (BIOVF) Q2 2022 Earnings Conference Call July 19, 2022 07:00 AM ET Company Participants Guido Oelkers - CEO Henrik Stenqvist - CFO Anders Ullman - Head, R&D and CMO Armin Reininger - Head of Medical and Scientific Affairs ...
Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q2 Non-GAAP EPS of -SEK0.91. Revenue of SEK3.87M (+20.6% Y/Y) misses by SEK352.44M . EBITA SEK 944 M (922); EBITA margin 24 per cent (29). Items affecting comparability ( IAC ) of SEK -14 M i...
The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2022 Q2 earnings call. For further details see: Swedish Orphan Biovitrum AB (publ) 2022 Q2 - Results - Earnings Call Presentation
Amid the biotech bear market, there are companies that are trading on a deep bargain, yet you should be extremely careful before averaging down. Though I noticed the fundamental changes in Galapagos, I gave the company a year to turn around. Here, I presented to you three differen...
Swedish Orphan Biovitrum AB (BIOVF) Q1 2022 Earnings Conference Call April 28, 2022 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Anders Ullman - Head of Research & Development, Chief Medical Officer Armin Reininger - H...
The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2022 Q1 earnings call. For further details see: Swedish Orphan Biovitrum AB (publ) 2022 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023